Point72 Asset Management, L.P. 13D and 13G filings for Fate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 7:50 pm Sale | 2024-09-30 | 13G | FATE THERAPEUTICS INC FATE | Point72 Asset Management, L.P. | 0 0.000% | -4,945,146 (Position Closed) | Filing |
| 2024-01-25 4:19 pm Purchase | 2024-01-24 | 13G | FATE THERAPEUTICS INC FATE | Point72 Asset Management, L.P. | 4,945,146 5.000% | 4,945,146 (New Position) | Filing |